Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs.

Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. Abstract Text:

    anna yarilinaAnna Yarilina,edward dicarloEdward DiCarlo,lionel b ivashkivLionel B Ivashkiv,

    Innate immune receptors that recognize nucleic acids, such as TLRs and RNA helicases, are potent activators of innate immunity that have been implicated in the induction and exacerbation of autoimmunity and inflammatory arthritis. Polyriboinosine-polyribocytidylic acid sodium salt (poly(IC)) is a mimic of dsRNA and viral infection that activates TLR3 and the RNA helicases retinoic acid-induced gene-1 and melanoma differentiation-associated gene-5, and strongly induces type I IFN production. We analyzed the effects of systemic delivery of poly(IC) on the inflammatory effector phase of arthritis using the collagen Ab-induced and KRN TCR-transgenic mouse serum-induced models of immune complex-mediated experimental arthritis. Surprisingly, poly(IC) suppressed arthritis, and suppression was dependent on type I IFNs that inhibited synovial cell proliferation and inflammatory cytokine production. Administration of exogenous type I IFNs was sufficient to suppress arthritis. These results suggest a regulatory role for innate immune receptors for dsRNA in modulating inflammatory arthritis and provide additional support for an anti-inflammatory function of type I IFNs in arthritis that directly contrasts with a pathogenic role in promoting autoimmunity in systemic lupus.

    Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. Publishing Authors By Initials

    a yarilinaA Yarilina,e dicarloE DiCarlo,lb ivashkivLB Ivashkiv,

    For similar virus diseases research abstracts see: virus diseases research

    PUBMED ID PMID:

    MEDLINE DATE:

    Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Journal of immunology (Baltimore, Md. : 1950)

    VOLUME: 178

    Page Numbers: 2204-11

    Journal Abbreviation: J. Immunol.

    ISSN: 0022-1767

    DAY: 15

    MONTH: Feb

    YEAR: 2007

    Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2985117

    Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. Keywords Mesh Terms:

    KEYWORDS: Virus Diseases

    MESH TERMS: pathology

    Chemical & Substance for Abstract: Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. Information

    Substance Name: RNA Helicases

    Registry Number: EC 2.7.7.-

    Grant and Affiliation Information for Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs.

    AFFILIATION: Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCRR

    GRANT: C06-RR12538-01

    ACRONYM: RR

    MEDLINETA: J Immunol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News